FDA-Approved Non-Small Cell Lung Cancer (NSCLC) Treatments
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
Oncology
FDA-Approved Breast Cancer Treatments
FDA-approved oral and injectable treatment options for breast cancer.
Brigatinib Receives Priority Review for First-Line Treatment of ALK+ Metastatic NSCLC
The Food and Drug Administration has granted Priority Review for the supplemental New Drug Application (sNDA) for brigatinib (Takeda) as a first-line treatment for patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC).
FDA-Approved Ovarian Cancer Treatments
FDA-Approved treatment options for individuals with ovarian cancer including dosing.
Antiemetic Treatments
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
FDA-Approved Prostate Cancer Treatments
Approved prostate cancer drug treatments including formulations and usual dosing.
Predictions in Medicine 2019: What’s Ahead
The editorial staff compiled a list of breakthroughs we and other experts foresee affecting oncologists and their patients in 2019. Take a look inside our crystal ball.
3 Social Media Do’s and Don’ts for Oncologists
Social media has become a popular networking and marketing platform for oncologists. Here’s what to do and what not to do on social media.
5 Ways to Make Social Media Work for Your Oncology Practice
Social media can be a valuable tool for oncologists. Here are 5 tips to make the most of it.
Next post in Practice Management
